Thyroid Cancer Therapeutics Market Share

Market Share of Thyroid Cancer Therapeutics Industry

The thyroid cancer therapeutics market is fragmented. The studied market is competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market include Sanofi (Genzyme Corporation), Exelixis, Inc, Medtronic Plc, Eisai Co., Ltd, Bayer AG, AbbVie Inc, Novartis AG, Pfizer Inc, Mylan N.V. and Bristol-Myers Squibb Company, among others.

Thyroid Cancer Therapeutics Market Leaders

1. Exelixis, Inc

2. Sanofi (Genzyme Corporation)

3. Medtronic Plc

4. Eisai Co., Ltd

5. Bayer AG

*Disclaimer: Major Players sorted in no particular order